Community-Engaged and T2 Research Funding Opportunities

The National Institute of Mental Health (NIMH) and the National Institute on Alcohol Abuse and Alcoholism (NIAAA), National Institutes of Health (NIH), seek to support collaborative intervention trials in the treatment, prevention or rehabilitation of those with mental disorders and alcohol use disorders and comorbid mental disorders. Support is also provided for other collaborative clinical studies, including but not limited to mental health services research, AIDS, genetics, psychopathology, stigma, and cultural and social processes.

Examples of the types of studies support by this grant include but are not limited to:

Large scale, public health oriented intervention studies (treatment, prevention, or rehabilitation)
Services research to identify mutable factors that impact access, utilization, quality, and outcomes of mental health services to inform or test patient-, provider-, organizational-, or policy- level services interventions
Studies of diffusion strategies (i.e., dissemination and implementation) to improve adoption of evidence-based treatments in practice settings

See: PAR-09-153

Health Promotion Among Racial and Ethnic Minority Males (R01)

Department of Public Health and Human Services
National Institute of Health (NIH)
National Institute of Nursing Research (NINR)
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
National Heart, Lung, and Blood Institute (NHLBI)
National Cancer Institute (NCI)
Office of Behavioral and Social Sciences Research (OBSSR)

Due Date: Standard Dates Apply
Expiration date: September 8, 2013

The focus of this FOA is on health promotion among racial and ethnic minority men. A scientific exploration of these disparities is central to NIHs commitment to reducing health disparities. Research in this area is essential to addressing Goal 2 outlined in Health People 2010: “To eliminate health disparities among segments of the population, including differences that occur by gender, race or ethnicity, education or income, disability, geographic location or sexual orientation.” Generally men access primary care facilities less often than women and are thus more inclined to delay accessing diagnostic services and treatments. Thus interventions in this area of study need to be innovative and cognizant of these patterns.

See: PA-10-236

Health Services Research on the Prevention and Treatment of Drug and Alcohol Abuse (R01)

National Institutes of Health (NIH)
National Institute on Drug Abuse (NIDA)
National Institute on Alcohol Abuse and Alcoholism (NIAAA)

Due Date: Standard Dates Apply
Expiration Date: May 8, 2012

This Funding Opportunity Announcement (FOA) encourages applications on health services research to improve the quality of prevention and treatment services for drug and alcohol abuse. Research projects might emphasize any of the following: (1) clinical quality improvement; (2) organizational/managerial quality improvement; (3) systems of care and collaborative research; or (4) development or improvement of research methodology, analytic approaches, and measurement instrumentation used in the study of drug and alcohol services.

See: PA-08-263

AHRQ Health Services Research Projects (R01)

Agency for Healthcare Research and Quality (AHRQ)

Due Date: Standard Dates Apply
Expiration Date: January 8, 2013

Research projects can have either a clinical or methodological emphasis, but must focus tightly on the study and/or the use of comparative effectiveness research. For applications with methodological emphasis, the goals should be to advance study designs and methods to fill specific knowledge gaps and to enhance the consistency, applicability, and generalizability of the comparative effectiveness studies. For applications with a clinical emphasis, the goals should be to develop new scientific evidence that fills important knowledge gaps and to generate critical insights on the clinical effectiveness and comparative clinical effectiveness of health care interventions. For studies in which randomized controlled trails may not be feasible or timely, or would raise ethical concerns that are difficult to address, novel or alternative study designs may be proposed. Such clinical research projects also need to be informed by the information needs and inputs from various stakeholders (e.g., policy-makers, providers, and patients) to ensure the most appropriate outcome measures for assessing the effectiveness of the interventions and outcomes of importance to stakeholders are included in the study. Research projects should also be organized around a set of priority conditions of importance to the Medicare, Medicaid, and SCHIP programs as mandated by the MMA section 1013.

See: PA-09-070

HIV/AIDS, Drug Use, and Vulnerable Populations in the US (R01)

National Institutes of Health (NIH)
National Institute on Drug Abuse (NIDA)
National Institute of Nursing Research (NINR)

Due Date: Standard Dates Apply
Expiration Date: September 8, 2012

This FOA encourages applications to identify the role(s) that drug abuse plays in fueling the HIV/AIDS epidemic in vulnerable groups (racial/ethnic minorities, men who have sex with men, youth) in the United States and to develop effective interventions to prevent new infections and to improve the health and well-being of those living with HIV/AIDS. This FOA will support studies to: 1) understand the contribution of drug abuse (both injection and non-injection) to the acquisition and/or transmission of HIV; 2) study disease progression and disease outcomes; 3) develop and/or improve prevention and treatment interventions; 4) address organizational, structural, and/or community level factors including social, drug-using, and sexual networks.

See: PA-09-236

Health Services Research on the Prevention and Treatment of Drug and Alcohol Abuse (R03)

National Institutes of Health (NIH)
National Institute on Drug Abuse (NIDA)
National Institute on Alcohol Abuse and Alcoholism (NIAAA)

Due Date: Standard Dates Apply
Expiration Date: May 8, 2012

See: PA-08-265

Community-Based Partnerships for Childhood Obesity Prevention and Control: Research to Inform Policy (R03)

Department of Health and Human Services
National Institutes of Health (NIH)
Centers for Disease Control and Prevention (CDC)
National Institute of Child Health and Human Development (NICHD)
National Cancer Institute (NCI)
National Heart, Lung, and Blood Institute (NHLBI)
Office of Behavioral and Social Sciences Research (OBSSR)
National Center for Chronic Disease Prevention and Health Promotion (NCCDPHP)

Due Date: Standard Dates Apply
Expiration Date: May 8, 2012

The NICHD has been leading an effort to promote a multilevel (or complex systems) approach to childhood obesity that recognizes individual food and physical activity behaviors as occurring not in isolation but as a function of the broader socio-environmental context. This approach requires that we simultaneously examine and address the range of biological and socio-environmental drivers (i.e., genes to policy) of diet and physical activity in order to build effective and sustainable intervention strategies. As part of this multilevel approach, the NICHD obesity program is seeking innovative ways to create opportunities for and generate best practices of researchers working with policymakers and other key stakeholders, such as health care practitioners, public health officials, community leaders, and educators, to develop solutions for childhood obesity. The goal is to have researchers and policymakers, and other stakeholders, participate in each phase of the research from conceiving, designing and conducting the research to analyzing, interpreting, and communicating the results. Community-based research processes offer the potential to generate better-informed and timely research questions and hypotheses, develop more effective interventions, and enhance the translation of the research results into practice.

See: PA-09-140

NIOSH Small Research Grant Program (R03)

National Institute for Occupational Safety and Health (NIOSH),
Centers for Disease Control and Prevention National Institute for Occupational Safety and Health (CDC/NIOSH)

Due Date: Standard Dates Apply
Expiration Date: September 8, 2012

The purpose of this grants program is to develop an understanding of the risks and conditions that are associated with occupational diseases and injuries, to explore methods for reducing risks and for preventing or minimizing exposure to hazardous conditions in the workplace, and to translate significant scientific findings into prevention practices and products that will effectively reduce work-related illnesses and injuries. The R03 grant mechanism supports different types of projects including pilot and feasibility studies; secondary analysis of existing data; small, self-contained research projects; development of research methodology; and development of new research technology. The R03 is intended to support small research projects that can be carried out in a short period of time with limited resources.

See: PA-OH-09-138

AHRQ Health Services Research Demonstration and Dissemination Grants (R18)

Agency for Healthcare Research and Quality (AHRQ)

Due Date: Standard Dates Apply
Expiration Date: January 8, 2013

Finding a way to improve the value of health care is a high priority for policy-makers, purchasers, consumers, and providers. Public and private decision makers in the field have been experimenting with ways to accomplish this goal, and AHRQ seeks to both facilitate and quickly learn from this rich body of "natural experiments." Changes in the organization of health care, payment, insurance and benefits redesign, and healthcare delivery redesigns provide real-world opportunities for rigorous, quicker, practical assessments of such experimentation to determine what works best, when, how, and for whom. Such experimentation provides opportunities to disseminate and diffuse relevant evidence garnered from such assessments in timely and effective ways to other similarly motivated public and private policymakers, health system and community leaders, and managers of healthcare organizations. Finally, efforts by employers, health plans, consumers, providers, community partnerships, and states to design and implement new approaches to improving the value of health care provide real-world "demonstration" sites; funding support can improve the likelihood for sustained success as well as the opportunity to learn quickly from both successes and failures.

AHRQ seeks to provide grants to facilitate and learn from these myriad natural experiments. Application teams should show strong support from (or leadership by) the change sites themselves, to advise, share information and data, partner (financially or in kind) and serve as "change agents" and dissemination outlets or agents for recent, current, and planned value-driven healthcare strategies. One purpose of such studies is to provide appropriately generalizable scientific findings about the consequences of value-driven experimentation for healthcare quality and costs, including how such issues relate to AHRQ's priority populations. A second purpose is to encourage experimentation and the spread of promising strategies for reducing waste and improving value.

See: PA-09-071

Health Services Research on the Prevention and Treatment of Drug and Alcohol Abuse (R21)

National Institutes of Health (NIH)
National Institute on Drug Abuse (NIDA)
National Institute on Alcohol Abuse and Alcoholism (NIAAA)

Due Date: Standard Dates Apply
Expiration Date: May 8, 2012

See: PA-08-264 (R21)

Health Promotion Among Racial and Ethnic Minority Males (R21)

Department of Public Health and Human Services
National Institute of Health (NIH)
National Institute of Nursing Research (NINR)
National Heart, Lung, and Blood Institude (NHLBI)
National Cancer Institute (NCI)
Office of Behavioral and Social Sciences Research (OBSSR)

Due Date: Standard Dates Apply
Expiration date: September 8, 2013

The focus of this FOA is on health promotion among racial and ethnic minority men. A scientific exploration of these disparities is central to NIHs commitment to reducing health disparities. Research in this area is essential to addressing Goal 2 outlined in Health People 2010: "To eliminate health disparities among segments of the population, including differences that occur by gender, race or ethnicity, education or income, disability, geographic location or sexual orientation." Generally men access primary care facilities less often than women and are thus more inclined to delay accessing diagnostic services and treatments. Thus interventions in this area of study need to be innovative and cognizant of these patterns.

See: PA-10-237

Community-Based Partnerships for Childhood Obesity Prevention and Control: Research to Inform Policy (R21)

Due Date: Standard Dates Apply
Expiration Date: May 8, 2012

See: PA-09-141

Exploratory Grants for Behavioral Research in Cancer Control (R21)

National Institutes of Health (NIH)
National Cancer Institute (NCI)
National Center for Complementary and Alternative Medicine (NCCAM)

Due Date: Standard Dates Apply
Expiration Date: May 8, 2012

This Funding Opportunity Announcement (FOA) invites applications in developmental and formative behavioral research in cancer prevention and control. This FOA will support innovative pilot projects or feasibility studies, which will facilitate the growth of research science in the cancer control continuum from a behavioral perspective. This FOA is appropriate for testing timely interventions in pilot studies for feasibility or using rigorous qualitative research methods to assess the potential efficacy of an intervention. It is also appropriate for the psychometric evaluation of new measures or culturally appropriate ones to be adapted for use in populations where measures have not yet been developed or validated.

See: PA-09-130

HIV/AIDS, Drug Use, and Vulnerable Populations in the US (R21)

National Institutes of Health (NIH)
National Institute on Drug Abuse (NIDA)
National Institute of Nursing Research (NINR)

Due Date: Standard Dates Apply
Expiration Date: September 8, 2012

See: PA-09-237

Pilot Intervention and Services Research Grants (R34)

National Institutes of Health (NIH)
National Institute of Mental Health (NIMH)

Due Date: Standard Dates Apply
Expiration Date: May 8, 2012

The purpose of this Funding Opportunity Announcement (FOA) is to encourage research on 1) the development and/or pilot testing of new or adapted interventions, 2) the adaptation and/or pilot testing of interventions with demonstrated efficacy for use in broader scale effectiveness trials, or 3) innovative services research directions that require preliminary testing or development. The R34 award mechanism provides resources for evaluating the feasibility, tolerability, acceptability and safety of novel approaches to improving mental health and modifying health risk behavior, and for obtaining the preliminary data needed as a pre-requisite to a larger-scale (efficacy or effectiveness) intervention or services study. NIMH intervention and services research is aimed at preventing or ameliorating mental disorders, emotional or behavioral problems, the co-occurrence of mental, physical and substance abuse problems, HIV infections, and the functional consequences of these problems across the life span. Innovative services research topics considered for this FOA include:

Research on factors that impact services organization, delivery (process and receipt of care), and financing in specialty mental health, general health, and other delivery settings (e.g., schools, the workplace, the criminal justice system).
Studies to develop novel service delivery models (e.g., aftercare services, rehabilitation, social setting, school or community-based, online/virtual communities) designed to target children, adolescents, adult or geriatric individuals with complex, comorbid and/or chronic conditions
Studies to develop organizational or systemic interventions to ease administrative burdens, reduce provider turnover or burnout, increase consumer satisfaction or improve service engagement
Research to identify effective dissemination and implementation processes and mechanisms to increase the uptake of scientifically informed treatments and services
Pilot studies to understand "real world" care delivery system characteristics that might facilitate or impede the integration of novel or adapted intervention techniques (e.g., reimbursing physicians for HIV risk reduction counseling during routine visits).
Studies to design or validate instruments to measure dissemination or implementation processes, changes in consumer functioning, or organizational environments.

See: PAR-09-173

Clinical Trial Planning Grant Program (R34)

National Institutes of Health (NIH)
National Eye Institute (NEI)
National Institute on Aging (NIA)
National Institute on Alcohol Abuse and Alcoholism
National Institute of Arthritis and Musculoskeletal and Skin Diseases
National Institute of Child Health and Human Development
National Institute on Drug Abuse (NIDA)
Office of Dietary Supplements (ODS)

Due Date: Standard Dates Apply
Expiration Date: May 8, 2012

This Funding Opportunity Announcement (FOA) invites applications under the NIH Clinical Trial Planning Grant Program, the purpose of which is to provide support for the development of a Phase III clinical trial. This includes the establishment of the research team, the development of tools for data management and oversight of the research, the definition of recruitment strategies, and the finalization of the protocol and other essential elements of the study included in a manual of operations/procedures. The Clinical Trial Planning Grant is not designed for the collection of preliminary data or the conduct of pilot studies to support the rationale for a clinical trial.

See: PA-09-186

Planning Grants for Translational Research for the Prevention and Control of Diabetes and Obesity (R34)

National Institutes of Health (NIH)
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Eunice Kennedy Shriver National Institute of Child Health and Human Development
Office of Behavioral and Social Sciences Research (OBSSR)

Due Date: Standard Dates Apply
Expiration Date: March 2, 2012

Several large, controlled clinical trials have established "gold standard" approaches for treating type 1 and type 2 diabetes, and for preventing or delaying type 2 diabetes in individuals at high risk for developing the disorder. Large controlled trials have also consistently demonstrated success in achieving weight loss though lifestyle approaches, although maintenance remains a challenge. Despite these advances, the efficacious interventions from these trials are rarely translated into widespread practice. Research is needed to develop and test innovative adaptations of evidence based approaches to prevent and treat diabetes and obesity that can be disseminated and sustained in clinical health care practice and other settings beyond the research environment.

See: PAR-09-177

Building System Capacity for Implementing Evidence-Based Practices in Substance Abuse Treatment and Prevention (R34)

National Institutes of Health (NIH)
National Institute on Drug Abuse (NIDA)

Due Date: Standard Dates Apply
Expiration Date: May 8, 2012

This Funding Opportunity Announcement provides resources to facilitate research on the adoption, implementation, and sustainability of evidence-based clinical treatment practices, prevention approaches, and business practices in community-based service delivery settings. Collaborations between service providers and entities that directly influence their capacity to deliver such practices, including Single State Agencies, other funders, educational entities, and other social services agencies that interact with the treatment and prevention systems are encouraged.

See: PA-09-105

Behavioral & Integrative Treatment Development Program (R34)

National Institutes of Health (NIH)
National Institute on Drug Abuse (NIDA)
National Institute on Alcoholism and Alcohol Abuse (NIAAA)

Due Date: Standard Dates Apply
Expiration Date: January 8, 2013

This FOA supports research to develop new innovative behavioral therapies or modify existing treatments to improve their effectiveness and devise ways to improve the engagement, retention, adherence, and outcome of alcoholism treatment across various populations of alcohol dependent and abuse subjects. NIDA and NIAAA are seeking applications that address any of the three Stages of treatment research supported under this initiative:

Stage I involves research on the development, manualization, refinement, improvement, adaptation, and pilot testing of behavioral and integrative treatment, HIV prevention, and therapist training interventions. Stage I may include translational studies involving research from other disciplines (e.g. basic science or neuroscience) conducted or utilized to gain information about mechanisms of behavior change and ultimately to develop new or improved interventions. Stage I may also include "community-friendly" research to adapt interventions that retain or increase their potency when modified for use in real-world settings.

Stage II includes larger-scale clinical trials or dose-response studies of piloted interventions that show promise. Of particular interest are studies that examine mechanisms of behavior change within the context of treatment research.

Stage III encompasses research aimed at ensuring that evidence-based interventions retain their effects in community settings (e.g., ERs, primary care, criminal justice settings, etc.). Stage III includes studies that examine whether interventions retain their efficacy when administered by community therapists. Stage III may also include studies that test training methods for community providers to administer evidence-based interventions.

See: PA-10-013

One-Time Funding Opportunities

Public Health Law Research: Making the Case for Laws That Improve Health 2011

Application Deadline: April 4, 2012, 3:00 PM EDT

To build the evidence for and strengthen the use of regulatory, legal and policy solutions to improve public health and help people lead healthier lives. PHLR is equally interested in identifying and ameliorating laws and legal practices that unintentionally harm health. PHLR’s purpose is to answer important questions, such as: How does law influence health and health behavior? Which laws have the greatest impact? Can current laws be made more effective through better enforcement, or do they require amendment?

RWJF encourages creativity and innovation in selecting and blending research methods. Innovative methods include experimental designs and simulations, the use of biological markers as outcome variables, mixed qualitative-quantitative studies, and the application of cutting-edge econometric and time-series models. Research teams must demonstrate expertise in both law and public health. Research teams that combine legal expertise with advanced research design and statistical competence are strongly encouraged. Successful proposals will normally demonstrate that the research team includes investigators with practice experience, and/or that the research plan is closely informed by practice. Cooperation with health officials and other public health and governmental practitioners will usually enhance practical relevance, as well as theoretical significance and methodological rigor.

More information, including award amounts, eligibility & selection criteria, key dates and applications are available here.

Contact: Public Health Law Research Grant Solicitation Helpdesk. Phone: (215) 204-2134.

Powered by CTSI

CTSI Main Navigation

Community-Engaged and T2 Research Funding Opportunities

Cyclical Funding Opportunities

One-Time Funding Opportunities

Cyclical Funding Opportunities

Collaborative R01s for Clinical and Services Studies of Mental Disorders, AIDS and Alcohol Use Disorders (R01)

Health Promotion Among Racial and Ethnic Minority Males (R01)

Health Services Research on the Prevention and Treatment of Drug and Alcohol Abuse (R01)

AHRQ Health Services Research Projects (R01)

HIV/AIDS, Drug Use, and Vulnerable Populations in the US (R01)

Health Services Research on the Prevention and Treatment of Drug and Alcohol Abuse (R03)

Community-Based Partnerships for Childhood Obesity Prevention and Control: Research to Inform Policy (R03)

NIOSH Small Research Grant Program (R03)

AHRQ Health Services Research Demonstration and Dissemination Grants (R18)

Health Services Research on the Prevention and Treatment of Drug and Alcohol Abuse (R21)

Health Promotion Among Racial and Ethnic Minority Males (R21)

Community-Based Partnerships for Childhood Obesity Prevention and Control: Research to Inform Policy (R21)

Exploratory Grants for Behavioral Research in Cancer Control (R21)

HIV/AIDS, Drug Use, and Vulnerable Populations in the US (R21)

Pilot Intervention and Services Research Grants (R34)

Clinical Trial Planning Grant Program (R34)

Planning Grants for Translational Research for the Prevention and Control of Diabetes and Obesity (R34)

Building System Capacity for Implementing Evidence-Based Practices in Substance Abuse Treatment and Prevention (R34)

Behavioral & Integrative Treatment Development Program (R34)

One-Time Funding Opportunities

Public Health Law Research: Making the Case for Laws That Improve Health 2011

QuickLinks

Research Resources

Training & Advancement

Funding

Collaboration Tools

For Community Partners

UCSF Single Sign-On Login